Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Torben Rixecker"'
Autor:
Sylvia Zöphel, Nadja Küchler, Johanna Jansky, Cora Hoxha, Gertrud Schäfer, Julius J. Weise, Joanne Vialle, Lea Kaschek, Gebhard Stopper, Hermann Eichler, Daniela Yildiz, Alina Moter, Philipp Wendel, Evelyn Ullrich, Claudia Schormann, Torben Rixecker, Onur Cetin, Frank Neumann, Patrick Orth, Moritz Bewarder, Markus Hoth, Lorenz Thurner, Eva C. Schwarz
Publikováno v:
Molecular Cancer, Vol 23, Iss 1, Pp 1-9 (2024)
Abstract Assessing the prognosis of patients with aggressive non-Hodgkin B cell lymphoma mainly relies on a clinical risk score (IPI). Standard first-line therapies are based on a chemo-immunotherapy with rituximab, which mediates CD16-dependent anti
Externí odkaz:
https://doaj.org/article/c26da19e6df140a2bd9fa86950fc9b73
Autor:
Sina A. Tegethoff, Guy Danziger, Dennis Kühn, Charlotte Kimmer, Thomas Adams, Lena Heintz, Carlos Metz, Katharina Reifenrath, Rebecca Angresius, Sebastian Mang, Torben Rixecker, André Becker, Jürgen Geisel, Christophe Jentgen, Frederik Seiler, Matthias C. Reichert, Franziska Fröhlich, Sascha Meyer, Jürgen Rissland, Sebastian Ewen, Gudrun Wagenpfeil, Katharina Last, Sigrun Smola, Robert Bals, Frank Lammert, Sören L. Becker, Marcin Krawczyk, Philipp M. Lepper, Cihan Papan
Publikováno v:
International Journal of Infectious Diseases, Vol 122, Iss , Pp 178-187 (2022)
ABSTRACT: Background: Early prognostication of COVID-19 severity will potentially improve patient care. Biomarkers, such as TNF-related apoptosis-inducing ligand (TRAIL), interferon gamma-induced protein 10 (IP-10), and C-reactive protein (CRP), migh
Externí odkaz:
https://doaj.org/article/63e8a4c4a910442baf706a2e3905c617
Autor:
Vadim Lesan, Moritz Bewarder, Carlos Metz, André Becker, Sebastian Mang, Evi Regitz, Lorenz Thurner, Frank Neumann, Igor Kos, Konstantinos Christofyllakis, Guy Danziger, Stephan Stilgenbauer, Robert Bals, Philipp M. Lepper, Dominic Kaddu-Mulindwa, Torben Rixecker
Publikováno v:
Intensive Care Medicine Experimental, Vol 9, Iss 1, Pp 1-10 (2021)
Abstract Background Despite numerous advances in the identification of risk factors for the development of severe coronavirus disease 2019 (COVID-19), factors that promote recovery from COVID-19 remain unknown. Natural killer (NK) cells provide innat
Externí odkaz:
https://doaj.org/article/3bce8a8d0e604692b023308f46e73a77
Autor:
Konstantinos Christofyllakis, Claudia Pföhler, Moritz Bewarder, Cornelia S. L. Müller, Lorenz Thurner, Torben Rixecker, Thomas Vogt, Stephan Stilgenbauer, Krista Yordanova, Dominic Kaddu-Mulindwa
Publikováno v:
Frontiers in Oncology, Vol 10 (2021)
IntroductionMultiple agents are approved in the adjuvant setting of completely resected high-risk (stages IIC–IV) malignant melanoma. Subgroups may benefit differently depending on the agent used. We performed a systematic review and meta-analysis
Externí odkaz:
https://doaj.org/article/68299114429c4768adb7887877e5b1ab
Autor:
Lorenz Thurner, Moritz Bewarder, Florian Rosar, Patrick Orth, Raoul Boris Meuter, Torben Rixecker, Vadim Lesan, Dieter Michael Kohn, Günther Schneider, Daniel Baumhoer, Rainer Maria Bohle, Christian Veith, Joerg Thomas Bittenbring
Publikováno v:
HemaSphere, Vol 5, Iss 1, p e511 (2021)
Externí odkaz:
https://doaj.org/article/4fa501dce18747cfbbf4758e2edb3007
Autor:
Carlos Metz, Torben Rixecker, Sebastian Mang, André Becker, Alexander Maßmann, Sören L. Becker, Cihan Papan, Barbara Gärtner, Frederik Seiler, Guy Danziger, Robert Bals, Philipp M. Lepper
Publikováno v:
Case Reports in Pulmonology, Vol 2021 (2021)
Background. In 2020, a novel coronavirus caused a global pandemic with a clinical picture termed COVID-19, accounting for numerous cases of ARDS. However, there are still other infectious causes of ARDS that should be considered, especially as the ma
Externí odkaz:
https://doaj.org/article/a9a3adac3ee6488e9c4a636360f267c6
Autor:
Sebastian, Mang, Guy, Danziger, Carlos, Metz, Torben, Rixecker, André, Becker, Albert J, Omlor, Christophe, Jentgen, Christian, Schmoll, Frederik, Seiler, Christian, Reyher, Ralf M, Muellenbach, Robert, Bals, Philipp M, Lepper
Publikováno v:
ASAIO Journal. 68:1017-1023
Coronavirus disease 2019 (COVID-19) has drastically increased the number of patients requiring extracorporeal life support. We investigate the efficacy and safety of low-dose recombinant tissue-type plasminogen activator (rtPA) injection into exhaust
Autor:
Sebastian Mang, Christian Reyher, Haitham Mutlak, Ruslan Natanov, Christopher Lotz, Daniel Gill-Schuster, Robert Bals, Guy Danziger, Patrick Meybohm, Alain Combes, Christian Kühn, Philipp M. Lepper, Ralf M. Muellenbach, Frederik Seiler, Carlos Metz, Torben Rixecker, Andre Becker, Marco Lubitz, Serguei Korboukov, Hartmut Lotz, Albert Omlor, Michael Tübben, Jovan Misic
Publikováno v:
American Journal of Respiratory and Critical Care Medicine. 205:847-851
Autor:
Ariane Stuhr, Stephan Stilgenbauer, Viola Poeschel, Hanneke C. Kluin-Nelemans, Niels Murawski, Moritz Bewarder, Rita Schuck, Jörg Thomas Bittenbring, Olivier Hermine, Eva Hoster, Sylvia Hartmann, Lorenz Thurner, Onur Cetin, Torben Rixecker, Natalie Fadle, Christiane Pott, Evi Regitz, Klaus-Dieter Preuss, Martin Dreyling, Dominic Kaddu-Mulindwa
Publikováno v:
Blood, 137(23), 3251-3258. AMER SOC HEMATOLOGY
Low-density lipoprotein (LDL) receptor-related protein-associated protein 1 (LRPAP1) had been identified by B-cell receptor (BCR) expression cloning and subsequent protein array screening as a frequent and proliferation-inducing autoantigen of mantle
Autor:
Frank Lammert, Sigrun Smola, Stephan Stilgenbauer, Philipp M. Lepper, Yvonne Bewarder, Andreas Link, Manfred Ahlgrimm, Stefan Wagenpfeil, Marcin Krawczyk, Martina Seiffert, Joerg Thomas Bittenbring, Frank Neumann, Benedikt Balensiefer, Lorenz Thurner, Dominic Kaddu-Mulindwa, Vadim Lesan, Igor Kos, Konstantin Christofyllakis, Torben Rixecker, Moritz Bewarder, Robert Bals
Publikováno v:
European Journal of Immunology
The pathogenesis of autoimmune complications triggered by SARS‐CoV2 has not been completely elucidated. Here, we performed an analysis of the cellular immune status, cell ratios, and monocyte populations of patients with COVID‐19 treated in the i